French Society of Hypertension has established a partnership with Women’s Cardiovascular Healthcare Foundation to alert women with high blood pressure at three key hormone stages. A tangible application of this partnership, the expert consensus entitled “HTA, Hormone et Femmes” (Hypertension, [...]
This is the main conclusion of a large American study just published in Biology of Sex Differences, which analyzed literature data from more than 5,400 references to determine whether gender differences in pharmacokinetic parameters predict differences in the occurrence of adverse events in men and [...]
Agir pour le Cœur des Femmes is driven by a single ambition: to reduce cardiovascular disease in France. To achieve this, our priority actions aim to save the lives of 100,000 women by 2030: - The development of care paths structured around women's health, with multidisciplinary care involving [...]